Evidence map›Paper›PMID 36840858›Full record

ReviewAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry2023

An overview of biochemical technologies for the cancer biomarker miR-21 detection.

Buyun Wei, Biao Huang, Xueqin Zhao

Abstract readReview
PubMed Publisher
In one paragraph

Review in Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Neuroprotection and Mechanism of Gas-miR36-5p fromInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Buyun WeiCollege of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Biao HuangCollege of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Xueqin ZhaoCollege of Life Science and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China. zhaoxueqin2004@163.com.
Zhejiang Sci-Tech University · CN

Funding

National Natural Science Foundation of China 31400797Zhejiang Provincial Natural Science Foundation of China LY18C100002
6 · The paper itself

Abstract

In recent years, the incidence of cancer has continuously increased, in which various miRNAs have been proposed as biomarkers for the early screening of cancer patients. As a consequence, the development of accurate methods for miRNA quantification has become a major research challenge worldwide. As one of the first discovered oncogenic miRNAs, microRNA-21 (miR-21) has been highlighted for its critical role in cancers. This review describes the main techniques currently available for miR-21 detection, compares the differences of the methods and the amplification strategies, and provides an overview of the state of knowledge in the field.

Indexed as

MicroRNAsNeoplasmsBiomarkers, TumorHumansBiomarkers, TumorMicroRNAsMIRN21 microRNA, humanCancer biomarkerElectrochemical biosensorsFluorescence resonance energy transferMiR-21Surface-enhanced Raman scattering

Identifiers

PMID36840858
OpenAlexW4321996919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.